In vitro and in vivo characterization of MPEP, an allosteric modulator of the metabotropic glutamate receptor subtype 5: Review article

Summary. There is a need to identify subtype-specific ligands for mGlu receptors to elucidate the potential of these receptors for the treatment of nervous system disorders. To date, most mGlu receptor antagonists are amino acid-like compounds acting as competitive antagonists at the glutamate binding site located in the large extracellular N-terminal domain.We have characterized novel subtype-selective mGlu5 receptor antagonists which are structurally unrelated to competitive mGlu receptor ligands. Using a series of chimeric receptors and point mutations we demonstrate that these antagonists act as inverse agonists with a novel allosteric binding site in the seven-transmembrane domain. Recent studies in animal models implicate mGlu5 receptors as a potentially important therapeutic target particularly for the treatment of pain and anxiety.

[1]  Z. Bortolotto,et al.  A novel, competitive mGlu5 receptor antagonist (LY344545) blocks DHPG‐induced potentiation of NMDA responses but not the induction of LTP in rat hippocampal slices , 2000 .

[2]  A. Reeve,et al.  mGlu5 receptors and nociceptive function II. mGlu5 receptors functionally expressed on peripheral sensory neurones mediate inflammatory hyperalgesia , 2001, Neuropharmacology.

[3]  M. J. Johnson,et al.  Antisense Ablation of Type I Metabotropic Glutamate Receptor mGluR1 Inhibits Spinal Nociceptive Transmission , 1998, The Journal of Neuroscience.

[4]  László Négyessy,et al.  Cellular, and subcellular localization of the mGluR5a metabotropic glutamate receptor in rat spinal cord , 1994, Neuroreport.

[5]  R. Shigemoto,et al.  Chapter III Metabotropic glutamate receptors — immunocytochemical and in situ hybridization analyses , 2000 .

[6]  R. Gereau,et al.  Peripheral group I metabotropic glutamate receptors modulate nociception in mice , 2001, Nature Neuroscience.

[7]  Shigetada Nakanishi,et al.  Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain , 1993, Neuroscience Letters.

[8]  R. Villalba,et al.  Differential distribution of metabotropic glutamate receptors 1a, 1b, and 5 in the rat spinal cord , 2000 .

[9]  W. Spooren,et al.  Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodents. , 2000, The Journal of pharmacology and experimental therapeutics.

[10]  M. Fendt,et al.  Metabotropic glutamate receptors are involved in amygdaloid plasticity , 2002, The European journal of neuroscience.

[11]  F. Porreca,et al.  Peripheral and spinal antihyperalgesic activity of SIB-1757, a metabotropic glutamate receptor (mGLUR5) antagonist, in experimental neuropathic pain in rats , 2000, Neuroscience Letters.

[12]  Andrzej Pilc,et al.  Anxiolytic-like effects of group I metabotropic glutamate antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) in rats. , 2000, Polish journal of pharmacology.

[13]  J. Pin,et al.  Pharmacology and functions of metabotropic glutamate receptors. , 1997, Annual review of pharmacology and toxicology.

[14]  A. Faden,et al.  Selective mGluR5 antagonists MPEP and SIB‐1893 decrease NMDA or glutamate‐mediated neuronal toxicity through actions that reflect NMDA receptor antagonism , 2000, British journal of pharmacology.

[15]  W. Zieglgänsberger,et al.  Differential distribution of metabotropic glutamate receptor subtype mRNAs in the thalamus of the rat , 2000, Brain Research.

[16]  D D Schoepp,et al.  A novel, competitive mGlu(5) receptor antagonist (LY344545) blocks DHPG-induced potentiation of NMDA responses but not the induction of LTP in rat hippocampal slices. , 2000, British journal of pharmacology.

[17]  F. Gasparini,et al.  SIB-1757 and SIB-1893: selective, noncompetitive antagonists of metabotropic glutamate receptor type 5. , 1999, The Journal of pharmacology and experimental therapeutics.

[18]  W. Zieglgänsberger,et al.  Distribution and developmental changes in metabotropic glutamate receptor messenger RNA expression in the rat lumbar spinal cord. , 1999, Brain research. Developmental brain research.

[19]  D. Jane,et al.  Pharmacological agents acting at subtypes of metabotropic glutamate receptors , 1999, Neuropharmacology.

[20]  W. Spooren,et al.  Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function I. Selective blockade of mGlu5 receptors in models of acute, persistent and chronic pain , 2001, Neuropharmacology.

[21]  M. Memo,et al.  mGluR5 metabotropic glutamate receptor distribution in rat and human spinal cord: a developmental study , 1997, Neuroscience Research.

[22]  S. Nakanishi,et al.  Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor , 2000, Nature.

[23]  A. N. van den Pol,et al.  Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain , 1995, The Journal of comparative neurology.

[24]  Roland Heckendorn,et al.  2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist , 1999, Neuropharmacology.

[25]  F. Gasparini,et al.  Potential anxiolytic‐ and antidepressant‐like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist , 2001, British journal of pharmacology.

[26]  F. Gasparini,et al.  Antagonism of the mGlu5 agonist 2‐chloro‐5‐hydroxyphenylglycine by the novel selective mGlu5 antagonist 6‐methyl‐2‐(phenylethynyl)‐pyridine (MPEP) in the thalamus , 1999, British journal of pharmacology.

[27]  A. N. van den Pol,et al.  Enhanced early developmental expression of the metabotropic glutamate receptor mGluR5 in rat brain: Protein, mRNA splice variants, and regional distribution , 1996, The Journal of comparative neurology.

[28]  J. Valtschanoff,et al.  Metabotropic glutamate receptors in superficial laminae of the rat dorsal horn , 1999, The Journal of comparative neurology.

[29]  Terri L. Gilbert,et al.  The ligand-binding domain in metabotropic glutamate receptors is related to bacterial periplasmic binding proteins , 1993, Neuron.